Safety and Feasibility of Same-day Discharge of Patients with Unresectable Hepatocellular Carcinoma Treated with Doxorubicin Drug-eluting Bead Transcatheter Chemoembolization
Authors:
- Shoaib RafiSRShoaib Rafi
- Bassel F. El-RayesBEBassel F. El-Rayes
- John S. KauhJKJohn S. Kauh
- David A. KoobyDKDavid A. Kooby
- Hyun S. KimHKHyun S. Kim
- 1 October 2012
- journal article
- research article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 23 (10) , 1286-1293.e1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2011
- Longitudinal Quality of Life Assessment of Patients with Hepatocellular Carcinoma after Primary Transarterial ChemoembolizationJournal of Vascular and Interventional Radiology, 2010
- Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Arterial Chemoembolization/Embolization and Early Complications after Hepatocellular Carcinoma Treatment: A Safe Standardized Protocol in Selected Patients with Child Class A and B CirrhosisJournal of Vascular and Interventional Radiology, 2009
- Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma with Drug Eluting Beads: Results of an Open-Label Study of 62 PatientsCardioVascular and Interventional Radiology, 2007
- Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?British Journal of Cancer, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987